Louis Simeone, DPM
Foot Surgery · Providence, RINPI 1841216256
Payments from drug & device makers
Across 31 payments — averaging $45.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$353
- Biotissue Holdings Inc.$340
- Smith+Nephew$222
- Dilon Technologies, Inc.$162
- GRT US Holding, Inc.$71
- Paratek Pharmaceuticals, Inc.$42
- plus $235 from 9 others
What the payments were for
- Food & beverage$1,425100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 1 | $353 |
| Biotissue Holdings Inc. | 5 | $340 |
| Smith+Nephew | 8 | $222 |
| Dilon Technologies, Inc. | 1 | $162 |
| GRT US Holding, Inc. | 3 | $71 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $41 |
| Integra Lifesciences Corporation | 1 | $37 |
| Amgen | 2 | $37 |
| Orthofix Medical, Inc. | 1 | $26 |
| Nevro Corp. | 1 | $24 |
| Osteomed LLC | 1 | $22 |
| Misonix Inc | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| KCI USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEOX$251
- CLARIX$251
- NAVIGATOR BIONAVIGATION SYSTEM$162
How this compares
Too few foot surgery providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 135 | $4,238 |
| Ammonium Lactate | 119 | $1,482 |
| Terbinafine Hcl | 60 | $510 |
| Methylprednisolone | 62 | $466 |
| Meloxicam | 63 | $435 |
| Amoxicillin | 71 | $274 |
| Gabapentin | 24 | $251 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $93 |
| Ibuprofen | 16 | $56 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Providence
- Edmund DosremediosProvidence$1K
- James McCormickWakefield$20K
- Eric BuchbaumWakefield$7K
- Thomas ManciniEast Greenwich$3K
- Thomas HuottRiverside$929
- Mark EnanderPawtucket$269
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.